23782872|t|Nutraceutical agents with anti-inflammatory properties prevent dietary saturated-fat induced disturbances in blood-brain barrier function in wild-type mice.
23782872|a|BACKGROUND: Emerging evidence suggests that disturbances in the blood-brain barrier (BBB) may be pivotal to the pathogenesis and pathology of vascular-based neurodegenerative disorders. Studies suggest that heightened systemic and central inflammations are associated with BBB dysfunction. This study investigated the effect of the anti-inflammatory nutraceuticals garlic extract-aged (GEA), alpha lipoic acid (ALA), niacin, and nicotinamide (NA) in a murine dietary-induced model of BBB dysfunction. METHODS: C57BL/6 mice were fed a diet enriched in saturated fatty acids (SFA, 40% fat of total energy) for nine months to induce systemic inflammation and BBB disturbances. Nutraceutical treatment groups included the provision of either GEA, ALA, niacin or NA in the positive control SFA-group and in low-fat fed controls. Brain parenchymal extravasation of plasma derived immunoglobulin G (IgG) and large macromolecules (apolipoprotein (apo) B lipoproteins) measured by quantitative immunofluorescent microscopy, were used as markers of disturbed BBB integrity. Parenchymal glial fibrillar acidic protein (GFAP) and cyclooxygenase-2 (COX-2) were considered in the context of surrogate markers of neurovascular inflammation and oxidative stress. Total anti-oxidant status and glutathione reductase activity were determined in plasma. RESULTS: Brain parenchymal abundance of IgG and apoB lipoproteins was markedly exaggerated in mice maintained on the SFA diet concomitant with significantly increased GFAP and COX-2, and reduced systemic anti-oxidative status. The nutraceutical GEA, ALA, niacin, and NA completely prevented the SFA-induced disturbances of BBB and normalized the measures of neurovascular inflammation and oxidative stress. CONCLUSIONS: The anti-inflammatory nutraceutical agents GEA, ALA, niacin, or NA are potent inhibitors of dietary fat-induced disturbances of BBB induced by systemic inflammations.
23782872	31	43	inflammatory	Disease	MESH:D007249
23782872	71	84	saturated-fat	Chemical	MESH:D005227
23782872	93	105	disturbances	Disease	MESH:D014832
23782872	151	155	mice	Species	10090
23782872	201	213	disturbances	Disease	MESH:D014832
23782872	314	341	neurodegenerative disorders	Disease	MESH:D019636
23782872	396	409	inflammations	Disease	MESH:D007249
23782872	430	445	BBB dysfunction	Disease	MESH:C536830
23782872	494	506	inflammatory	Disease	MESH:D007249
23782872	522	541	garlic extract-aged	Chemical	-
23782872	543	546	GEA	Chemical	-
23782872	549	566	alpha lipoic acid	Chemical	MESH:D008063
23782872	568	571	ALA	Chemical	MESH:D008063
23782872	574	580	niacin	Chemical	MESH:D009525
23782872	586	598	nicotinamide	Chemical	MESH:D009536
23782872	609	615	murine	Species	10090
23782872	641	656	BBB dysfunction	Disease	MESH:C536830
23782872	667	674	C57BL/6	CellLine	CVCL:C0MU
23782872	675	679	mice	Species	10090
23782872	708	729	saturated fatty acids	Chemical	MESH:D005227
23782872	731	734	SFA	Chemical	MESH:D005227
23782872	796	808	inflammation	Disease	MESH:D007249
23782872	817	829	disturbances	Disease	MESH:D014832
23782872	895	898	GEA	Chemical	-
23782872	900	903	ALA	Chemical	MESH:D008063
23782872	905	911	niacin	Chemical	MESH:D009525
23782872	942	945	SFA	Chemical	MESH:D005227
23782872	1031	1047	immunoglobulin G	Gene	668542
23782872	1049	1052	IgG	Gene	668542
23782872	1233	1263	glial fibrillar acidic protein	Gene	14580
23782872	1265	1269	GFAP	Gene	14580
23782872	1275	1291	cyclooxygenase-2	Gene	19225
23782872	1293	1298	COX-2	Gene	19225
23782872	1355	1381	neurovascular inflammation	Disease	MESH:D007249
23782872	1434	1455	glutathione reductase	Gene	14782
23782872	1532	1535	IgG	Gene	668542
23782872	1540	1544	apoB	Gene	238055
23782872	1586	1590	mice	Species	10090
23782872	1609	1612	SFA	Chemical	MESH:D005227
23782872	1659	1663	GFAP	Gene	14580
23782872	1668	1673	COX-2	Gene	19225
23782872	1737	1740	GEA	Chemical	-
23782872	1742	1745	ALA	Chemical	MESH:D008063
23782872	1747	1753	niacin	Chemical	MESH:D009525
23782872	1787	1790	SFA	Chemical	MESH:D005227
23782872	1799	1818	disturbances of BBB	Disease	MESH:C536830
23782872	1850	1876	neurovascular inflammation	Disease	MESH:D007249
23782872	1921	1933	inflammatory	Disease	MESH:D007249
23782872	1955	1958	GEA	Chemical	-
23782872	1960	1963	ALA	Chemical	MESH:D008063
23782872	1965	1971	niacin	Chemical	MESH:D009525
23782872	2024	2043	disturbances of BBB	Disease	MESH:C536830
23782872	2064	2077	inflammations	Disease	MESH:D007249
23782872	Positive_Correlation	MESH:D005227	MESH:C536830
23782872	Positive_Correlation	MESH:D005227	MESH:D014832
23782872	Positive_Correlation	MESH:D005227	19225
23782872	Negative_Correlation	MESH:D008063	MESH:D007249
23782872	Negative_Correlation	MESH:D009525	MESH:C536830
23782872	Positive_Correlation	MESH:D005227	238055
23782872	Negative_Correlation	MESH:D009525	MESH:D007249
23782872	Positive_Correlation	MESH:D005227	14580
23782872	Negative_Correlation	MESH:D005227	MESH:D009525
23782872	Negative_Correlation	MESH:D005227	MESH:D008063
23782872	Positive_Correlation	19225	238055
23782872	Positive_Correlation	MESH:D005227	668542
23782872	Positive_Correlation	14580	668542
23782872	Negative_Correlation	MESH:D009536	MESH:D007249
23782872	Negative_Correlation	MESH:D008063	MESH:C536830

